Susana Marcos, co-founder of 2Eyes Vision, was awarded the Prize eWoman Salamanca for her professional career, in an event sponsored by CaixaBank, Prensa Iberica and La Gaceta de Salamanca. The event promoted the talent of women and rewards the best entrepreneurship and innovation models.
Here you can find more information about the award and the ceremony.
First validation of the simulation of commercial intraocular lenses by SimVis, published in Scientific Reports
Multifocal intraocular lenses are used to provide patients to functional vision at various distances. In a recent paper published in Scientific Reports we demostrated the equivalency of through focus visual acuity with real lenses (a bifocal refractive IOL and a trifocal diffractive IOL) and the same lenses simulated in a Spatial Light Modulator and SimVis technology (temporal multiplexing).
Full citation: Maria Vinas, Clara Benedi-Garcia, Sara Aissati, Daniel Pascual, Vyas Akondi, Carlos Dorronsoro & Susana Marcos. Visual simulators replicate vision with multifocal lenses. Scientific Reports 9, 1539 (2019).
Full article here.
CSIC Press release here.
CSIC and VioBio Lab have presented the validation and launch of SimVis in a press conference that took place last February 7th at CSIC.
The press conference, was led by Prof. Susana Marcos (Director of VioBio Lab, Co-Inventor of the SimVis technology and 2Eyes Vision co-founder), and María Viñas, Researcher at VioBio Lab, with the attendance of Carlos Dorronsoro, (Co-Inventor of the SimVis technology and 2Eyes Vision co-founder), Álvaro Sánchez-Lozano, Business Developer of 2Eyes Vision, and Enrique Gambra, CTO of 2Eyes Vision
Thanks to SimVis, developed by researchers from the VioBio Lab (CSIC), patients and surgeons have the possibility of seeing the effects of an intraocular multifocal lens realistically before the implantation. This revolutionary concept caught the interest of several media, including Spanish public television (RTVE)
“Visual simulators are an ideal technique to provide patients with a realistic experience of multifocality before the implantation of an intraocular lens. In addition, since the device has been reduced in size and has a more practical design than those currently in the market, the benefits multiply, ” Prof. Marcos concluded during the press conference.
The technology has led to four patents (one of them received the Best Patent of the Year Award from the Madrid+d Foundation) licensed to 2Eyes Vision, a spin-off company from CSIC, funded, among others, by several of the researchers involved in the development of SimVis.
More information about the press conference in the following links: